Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01275846 · ClinicalTrials.gov registry record · NA
Deployment of American Heart Association Heart Failure Protocols and Content Within the Intel® Health Guide System
A NA study, sponsored by American Heart Association.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01275846: Completed NA study, sponsored by American Heart Association.
NCT01275846 is a NA study that has completed, run by American Heart Association. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01275846, a NA study, has completed, sponsored by American Heart Association.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This purposed of this study is to ascertain if the implementation of remote patient management systems utilizing American Heart Association (AHA) guideline-based heart failure protocols and educational content can improve the management of patients with congestive heart failure.
Primary Outcome
Measuring the percentage of available days the patient measures and records his/her vitals (weight, blood pressure, blood oxygen saturation level, glucose level) and completes his/her protocol sessions during the monitoring period. Utility was defined as days of activity and interaction of the patient with the monitor / days of actual monitoring possible.
Interventions
- DEVICE Health Guide using AHA heart failure protocols and content
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-03 |
| Phase | NA |
What the finished NCT01275846 record still lists
NCT01275846 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Health Guide using AHA heart failure protocols and content is the first listed.
NCT01275846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01275846 about?
NCT01275846 is a clinical study titled "Deployment of American Heart Association Heart Failure Protocols and Content Within the Intel® Health Guide System". This purposed of this study is to ascertain if the implementation of remote patient management systems utilizing American Heart Association (AHA) guideline-based heart failure protocols and educational content can improve the management of patients with congestive heart failure.
What is the current status of trial NCT01275846?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2010-06. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01275846?
The interventions under investigation include: Health Guide using AHA heart failure protocols and content (DEVICE).
Who is sponsoring clinical trial NCT01275846?
This trial is sponsored by American Heart Association, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01275846's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia